<DOC>
	<DOCNO>NCT02150707</DOCNO>
	<brief_summary>This study aim determine different diabetes treatment different effect inflammation ; particular , kidney inflammation . This type inflammation common people diabetes , lead kidney failure . This study investigate effect different type diabetes treatment kidney inflammation . This help u decide certain type medicine prefer people evidence inflammation kidney , may help prevent major complication include kidney failure .</brief_summary>
	<brief_title>The Differential Effects Diabetes Therapy Inflammation</brief_title>
	<detailed_description>In prospective cohort study , patient clinically determine require escalation glycaemic therapy , prescribe DPP4 inhibitor , GLP-1 receptor agonist , insulin , invited participate . Blood urine sample take , 4 8 week , 26 week start new therapy . Markers inflammation , renal function glycemic control measure timepoint .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>Age 30 year Diagnosis type 2 diabetes one year Diagnosis DKD define two distinct albumin : creatinine ratio measurement gender specific range local reference laboratory interval less eight week measurement Stable dose inhibitor renin angiotensin system period 8 week Any cognitive impediment preclude participant give free inform consent Substance abuse include alcohol excess Use GLP1 analogue last 6 month Pregnancy Hypersensitivity prescribe treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>